- Brand name eyeglasses, Frames, contact lenses, Sunglasses, Safety Glasses, and Quality Replacement Lenses at the most affordable prices

Shop Our Products


Ophthalmic industry keeps focus on patient care during COVID-19

As practicing optometrists and their staffs have adjusted hours and operations amidst the new environment brought on by the COVID-19 pandemic, so too has the eye care industry found avenues to continue business and provide much-needed information and products to physicians and the public. The most important thing for us is that the messages were sending out to the optometric community are focused, relevant and sensitive to the situation that they find themselves in as care givers, as small busin...

>Read More

PPV, subretinal tissue plasminogen activator injection effective for submacular hemorrhage

Pars plana vitrectomy with subretinal tissue plasminogen activator injection led to significant vision improvement in patients with fovea-involving macular hemorrhage, according to a study. Patients with submacular hemorrhage from any cause should be considered for this intervention, recognizing that each patients suitability for this may be limited by preoperative vision, ability to undergo surgery and other usual considerations for interventions, study co-author Carl S. Wilkins, MD, told Heali...

>Read More

Optometry's Meeting canceled in response to COVID-19

The 2020 Optometrys Meeting, originally scheduled for June 24 to 28 in Washington, D.C., has been canceled as part of the organizations commitment to prioritize the health and safety of members, staff and attendees along with their families and patients, according to an announcement from American Optometric Association president Barbara L. Horn, OD, and American Optometric Student Association presidentelect Alex J. Bennett. This is the first time that Optometrys Meeting has been canceled, and wh...

>Read More

Improve breast cancer survival through knowledge, behaviors, coordination

Although significant progress has been made in breast cancer care, challenges and opportunities remain in cancer survivorship. There are a growing number of breast cancer survivors. It is estimated that there will be more than 18 million cancer survivors in the U.S. alone by 2022, of whom 22% are expected to be female breast cancer survivors, Ann H. Partridge, MD, MPH, founder and director of the program for young women with breast cancer and director of the adult survivorship program at Dana-Fa...

>Read More

VIDEO: Telehealth a huge challenge with tremendous upside

Marian Macsai, MD, a cornea specialist at NorthShore University HealthSystem in Chicago, discusses the challenges of implementing telehealth but also outlines reasons why she thinks the switch to more telehealth may be the best thing to emerge from the COVID-19 pandemic for physicians....

>Read More

Xen approved for refractory glaucoma in China

Chinas National Medical Products Administration approved the use of the Xen gel stent for the surgical management of patients with refractory glaucoma, according to an Allergan press release. The National Medical Products Administration and Hainan Provincial Government created a real-world evidence pilot program in June 2019. When combined with data from controlled clinical trials, the real-world data enabled the assessment of ethnic differences to treatment with Xen, which helped to support the...

>Read More

Eyevance launches Zerviate in US

Eyevance Pharmaceuticals has launched Zerviate, a treatment for ocular itching related to allergic conjunctivitis, in the United States, according to a press release. Zerviate (cetirizine ophthalmic solution 0.24%) is formulated with the vehicle Hydrella, which contains glycerin and hydroxypropyl methylcellulose. These are common in tear lubricants and help to comfortably deliver the cetirizine molecule, the release said. Eyevance is building its core business around the commercialization of sta...

>Read More